Massachusetts' highest court signaled this week that it may revisit a $165 million judgment against three UnitedHealth-owned companies. The ruling stemmed from allegations of deceptive marketing practices. The court's potential review centers on how the original judge calculated the restitution portion of the judgment.
The development comes after a hearing held on October 9, 2026. During the proceedings, justices raised questions about the transparency of the restitution calculation. They hinted that the lower court judge might need to provide a more detailed explanation for the $165 million figure.
The case revolves around claims that the UnitedHealth-owned companies engaged in misleading marketing tactics. The original judgment included both punitive damages and restitution to affected parties. The Massachusetts court's decision to potentially re-examine the case could impact the final outcome for all parties involved.